Caffeine in Food and Dietary Supplements: Examining Safety
Planning Committee on Potential Health Hazards Associated with
Consumption of Caffeine in Food and Dietary Supplements
August 5–6, 2013
WORKSHOP OBJECTIVES
Evaluate the epidemiological, toxicological, clinical, and other
relevant literature to describe important health hazards associated
with caffeine consumption
Delineate vulnerable populations who may be at risk from caffeine
exposure
Describe caffeine exposure and risk of cardiovascular and other
health effects on vulnerable populations, including additive effects
with other ingredients and effects related to preexisting
conditions
Explore safe caffeine exposure levels for general and vulnerable
populations
Identify data gaps on caffeine stimulant effects including but not
limited to cardiovascular, central nervous system, or other health
outcomes
INTRODUCTION AND OPENING REMARKS
View in own window
8:50 a.m. |
Welcome
Lynn Goldman, George Washington
University, Chair, Planning Committee on Potential
Health Hazards Associated with Consumption of
Caffeine in Food and Dietary Supplements
|
9:00 a.m. |
Opening Remarks
|
SESSION 1: INTAKE AND EXPOSURE TO CAFFEINE
View in own window
|
Moderated by Barbara Petersen, Exponent
|
9:15 a.m. |
Examining Exposure to Caffeine in Foods, Beverage,
and Supplements
|
Caffeine Intakes from Beverages in the United
States
|
Trends in Caffeine Consumption
|
10:00 a.m. |
Panel Discussion with Speakers
|
10:30 a.m. |
Break
|
SESSION 2: SAFETY SIGNALS AND SURVEILLANCE OF POPULATIONS
View in own window
|
Moderated by Steve Lipshultz, University of
Miami
|
10:50 a.m. |
Type and Frequency of Caffeine Toxicity: U.S. and
International Surveillance
|
11:10 a.m. |
Safety Assessment of Caffeine in Foods and
Beverages
|
11:30 a.m. |
Panel Discussion with Speakers
|
12:00 p.m. |
Break for Lunch
|
SESSION 3: CAFFEINE EFFECTS ON THE CARDIOVASCULAR SYSTEM
View in own window
|
Moderated by Stephen Daniels, Children's
Hospital, University of Colorado, Denver
|
1:00 p.m. |
Vascular Effects of Caffeine
|
1:20 p.m. |
Caffeine and Risk of Arrhythmia
|
1:40 p.m. |
Caffeine and Risk of Hypertension
|
2:00 p.m. |
Panel Discussion with Speakers
|
SESSION 4: CAFFEINE EFFECTS ON THE CENTRAL NERVOUS SYSTEM
View in own window
|
Moderated by Thomas Gould, Temple
University
|
2:20 p.m. |
Neuropharmacologic Effects of Caffeine
Exposure
|
2:40 p.m. |
Developmental Neurological Effects of Caffeine
Exposure
|
3:00 p.m. |
Panel Discussion with Speakers
|
3:20 p.m. |
Break
|
SESSION 5: PANEL DISCUSSION: BEHAVIORAL EFFECTS ASSOCIATED WITH
CAFFEINE CONSUMPTION
View in own window
|
Moderated by Richard Adamson, TPN
Associates
|
3:30 p.m. |
Dependence/Tolerance
|
Addiction
|
Risk Taking
|
4:30 p.m. |
Public Comments
|
PUBLIC COMMENTS AND CONCLUDING REMARKS
View in own window
5:00 p.m. |
Concluding Remarks for Day 1
Lynn Goldman, George Washington
University, Chair, Planning Committee on Potential
Health Hazards Associated with Consumption of
Caffeine in Food and Dietary Supplements
|
5:10 p.m. |
Adjourn Meeting
|
August 6, 2013
|
8:50 a.m. |
Welcome and Summary from Day 1
Lynn Goldman, George Washington
University, Chair, Planning Committee on Potential
Health Hazards Associated with Consumption of
Caffeine in Food and Dietary Supplements
|
9:00 a.m. |
Opening Remarks
|
SESSION 1: OTHER COMPOUNDS IMPACTING CAFFEINE EFFECTS
View in own window
|
Moderated by James Coughlin, Coughlin &
Associates
|
9:15 a.m. |
Facilitated Discussion: Other Components Impacting
Caffeine Effects
|
Summary of the Issues
|
Panel Discussion
|
SESSION 2: USE OF CAFFEINATED PRODUCTS
View in own window
|
Moderated by: James Coughlin, Coughlin &
Associates
|
10:15 a.m. |
Trends in Usage and Potential Benefits from
Caffeine
|
10:35 a.m. |
Q&A
|
SESSION 3: EXPLORING SAFE CAFFEINE EXPOSURE LEVELS
View in own window
10:45 a.m. |
Panel Discussion: Exploring Safe Caffeine Exposure
Levels for Vulnerable Populations
|
Panel Moderator
|
Pregnancy/Infants
|
Children/ Young Adults
|
11:30 a.m. |
Break for Lunch
|
SESSION 4: DATA GAPS
View in own window
|
Moderated by Joe Rodricks, Environ
International
|
12:30 p.m. |
Panel Discussion on Data Gaps and Future
Research
Stephen Schaffer, University of South
Alabama
Christina Chambers, University of
California, San Diego
Steve Lipshultz, University of
Miami
Regan Bailey, National Institutes of
Health, Office of Dietary Supplements
Amelia Arria, University of Maryland,
College Park
Alvin Bronstein, Rocky Mountain Poison
Center
|
1:45 p.m. |
Chair's Summary and Final Thoughts
Lynn Goldman, George Washington
University, Chair, Planning Committee on Potential
Health Hazards Associated with Consumption of
Caffeine in Food and Dietary Supplements
|
2:00 p.m. |
Adjourn Meeting
|